Methods for catalyzing CH insertion reactions using heme enzymes are described. The present disclosure provides a method for producing a CH insertion product comprising providing an substrate having an sp.sup.3-hybridized CH bond, a carbene precursor such as a diazo reagent, and a heme enzyme, and admixing the components in a reaction for a time sufficient to produce the CH insertion product. Heme enzyme variants useful for carrying out in vivo and in vitro CH insertion reactions, as well as expression vectors and host cells expressing the heme enzymes, are also described.

Methods for catalyzing CH insertion reactions using heme enzymes are described. The present disclosure provides a method for producing a CH insertion product comprising providing an substrate having an sp.sup.3-hybridized CH bond, a carbene precursor such as a diazo reagent, and a heme enzyme, and admixing the components in a reaction for a time sufficient to produce the CH insertion product. Heme enzyme variants useful for carrying out in vivo and in vitro CH insertion reactions, as well as expression vectors and host cells expressing the heme enzymes, are also described.

The present technology relates to the production of chemical species in bacterial or yeast host cells. Particularly, the present technology provides for the production of chemical species in microbial host cells that functionally express engineered P450 enzymes.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical, personal care and/or animal care products and applications.

Antimicrobial compositions comprising one or more compound components generally recognized as safe for human consumption, and related methods of use, such compositions and methods as can be employed in a wide range of agricultural, industrial, building, pharmaceutical, personal care and/or animal care products and applications.

The invention relates to a mixture composition comprising glucolipids, to its use for producing formulations and to formulations comprising this mixture composition.

Processes and systems for recovering products from a corn fermentation mash. In one example, a process for recovering products from a corn fermentation mash can include separating ethanol from a fermentation mash to produce a whole stillage. The fermentation mash can be derived from a ground corn product milled from a plurality of corn pieces. The plurality of corn pieces can include whole corn kernels, fragmented corn kernels, size-reduced corn kernels, milled corn kernels, or a mixture thereof. Greater than 25 wt % of the ground corn product can have a particle size of greater than 105 ?m and greater than 80 wt % of the ground corn product can have a particle size of 425 ?m or less, as measured according to AOAC 965.22-1966. The process can also include separating the whole stillage to produce a fiber rich portion and a filtrate.

Disclosed are genetically engineered organisms, such as yeast and bacteria, that have the ability to metabolize atypical phosphorus or sulfur sources. Fermentation methods using the genetically engineered organisms are also described. The fermentation methods are robust processes for the industrial bioproduction of a variety of compounds, including commodities, fine chemicals, and pharmaceuticals.

The invention relates to enzymatic methods for epoxidation of a non-cyclic aliphatic alkene, or a terpene.

The invention relates to enzymatic methods for epoxidation of a non-cyclic aliphatic alkene, or a terpene.